Navigation Links
Fruitfly Model of a Neuropathic Disease Demonstrates Novel Role for Proteins in the Family of aTyr Pharma's Product Class
Date:7/13/2009

SAN DIEGO, July 13 /PRNewswire/ -- Research published in the June 26, 2009 edition of Proceedings of National Academy of Sciences provides further evidence for novel roles of tRNA synthetases in disease, validating the therapeutic potential for aTyr Pharma's new class of naturally occurring protein agents. The aminoacyl tRNA synthetases are universal and essential components of protein synthesis machinery found in all organisms, but human synthetases have naturally occurring resected variants with potent cell signaling activities that are vital to normal functioning of humans. aTyr Pharma's proprietary product generating engine consists of these resected proteins (resectins) of human aminoacyl tRNA synthetases with cell signaling activities distinct from the protein synthesis activities. In this recently published study, a model of a human neuropathy was created in the fruit fly (Drosophila) by introducing mutations in the tyrosyl-tRNA synthetase which correspond to disease associated mutations in humans. These dominant mutations do not cause a loss in the protein synthesis activity, indicating that the neuropathy arises from distinct activities of this tRNA synthetase. This work provides further proof of noncanonical roles for tRNA synthetases in human disease.

The large team of scientists on the study included Professors Paul Schimmel and Xiang-Lei Yang, scientific co-founders of aTyr Pharma, and Leslie Nangle, Director of Research at aTyr Pharma, and was led by Albena Jordanova of the University of Antwerp. Other scientists contributing to this paper are from the University of Antwerp, Universiteit Leuven, and Florida Atlantic University. Professor Paul Schimmel of The Scripps Research Institute describes the significance of the work. "Charcot-Marie-Tooth (CMT) is one of the most common inherited neurological disorders, with typical symptoms usually emerging in early adulthood,
'/>"/>

SOURCE aTyr Pharma
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
2. Targanta Presents First Data Demonstrating In Vitro Activity and In Vivo Efficacy of Prodrugs in Osteomyelitis Models
3. KineMed Presents Preclinical Data for Investigational Agent Demonstrating Neurogenesis and Confirming Improvements in Behavioral Model
4. EntreMed Shows Increased Survival With MKC-1 in Preclinical Renal Cell Cancer Model
5. NKTR-102 (PEG-Irinotecan) Demonstrates Significant Tumor Growth Inhibition In Multiple Preclinical Tumor Models
6. VIA Pharmaceuticals Presents Data at American Heart Association Meeting Showing VIA-2291 Significantly Reduces Inflammation in Preclinical Model of Atherosclerosis
7. New Data Confirms That a Selective, Fully Human Anti-VEGF Antibody Being Developed by Peregrine is as Effective as Avastin(R) in Preclinical Cancer Models
8. Pharsight Uses FDA Disease Model to Support Oncology Drug Development
9. CSL Behring Study in Animal Models Shows Feasibility of Developing a Half-Life Extended Recombinant FVIIa that Retains Biologic Activity
10. Researchers Train the Immune System to Deliver Virus That Destroys Cancer in Lab Models
11. Anadys Pharmaceuticals Announces Positive Results for ANA598 in Animal Model of Chronic Hepatitis C Virus Infection

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...,, PITTSBURGH,Nov.24/PRNewswire/-- ,, WHA...23yearsfollowinganautoaccident,wasactuallyfullycon...dMorningAmericasegment.TheDynaVoxEyeMaxwasfeatured...romeandotherconditionscanunlockcommunication. ,...ilableonlineat www.dynavoxtech.com ,, WH...
(Date:11/24/2009)...,, SANDIEGO,Nov.24/PRNewswire-FirstCall/--An...daythatitwillpresentatthe21stAnnualPiperJaffrayHea....EST(6:00a.m.PST).TheconferenceisbeingheldatTheNew...efExecutiveOfficerofAnadys,willprovideanoverviewof...NA773. ,, Thecorporatepresentationwillbesimulta...
(Date:11/24/2009)...,, SANDIEGO,Nov.24/PRNewswire/--Accumetrics,...yNow®System,thefirstrapidandeasy-to-usediagno...ipleantiplateletagents(e.g.Plavix®andaspirin)...fAccumetrics,andGregoryJ.Tibbitts,ChiefFinancialOf...iewatthe21stAnnualPiperJaffrayHealthCareConference...
Breaking Medicine Technology:DynaVox EyeMax Featured in Good Morning America Segment About Man Thought To Be in Coma for 23 Years 2Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Accumetrics to Present at the 21st Annual Piper Jaffray Health Care Conference 280 Million European Runners Reveal Their Reasons to Run 55673 180 Million European Runners Reveal Their Reasons to Run 55673 280 Million European Runners Reveal Their Reasons to Run 55673 3Flu Shots Now Available for 2009 Seasonal Influenza at MD Now Urgent Care Centers in Palm Beach County Florida 55670 1Flu Shots Now Available for 2009 Seasonal Influenza at MD Now Urgent Care Centers in Palm Beach County Florida 55670 2Flu Shots Now Available for 2009 Seasonal Influenza at MD Now Urgent Care Centers in Palm Beach County Florida 55670 3Flu Shots Now Available for 2009 Seasonal Influenza at MD Now Urgent Care Centers in Palm Beach County Florida 55670 4Tarascon Publishing Presents Essential Translation Resource for Healthcare Providers with Non English Speaking Patients 55667 1Tarascon Publishing Presents Essential Translation Resource for Healthcare Providers with Non English Speaking Patients 55667 2Tarascon Publishing Presents Essential Translation Resource for Healthcare Providers with Non English Speaking Patients 55667 3
...lts from Exploratory Phase IIa Clinical Trial in T...8, 2007 /PRNewswire-FirstCall/ - Transition,Therap...esults from,its exploratory Phase IIa clinical tri...h gastrin-based therapy, E1-I.N.T.(TM), showed,sus...ers, including,haemoglobinA1C (HbA1c), for 6 month...
...ON, June 28, 2007 /PRNewswire/ - Cytochroma Inc.,a...al trial of,CTA018 Injection. The initial top-line...fe and well tolerated. Complete study,results are ...Phase I trial was an open label,placebo-controlle...ed to 20 healthy volunteers. In this trial, the sa...
Other Medicine Technology:A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 2A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 3A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 4A 4-Week Therapy with Transition Therapeutics' E1-I.N.T. Leads to,Sustained Reductions in Blood Glucose Levels for 6 Months,Post-treatment in Type 2 Diabetes Patients 5Cytochroma Reports Positive Phase I Clinical Data for CTA018,Injection 2Cytochroma Reports Positive Phase I Clinical Data for CTA018,Injection 3
(Date:11/25/2009)...,, KANSASCITY,Mo.,Nov.25/PRNewswire/--TheBart...on,slargestmedicalcliniconDec.9-10,whenKansasCityh...uredpeople. ,, "Thisfreecliniceventhasthepotent...daysinsteadofjustoneandbeheldonweekdaysinsteadofov...CityFreeHealthClinicandpresidentoftheNationalAssoc...
(Date:11/25/2009)...,, TORONTO,Nov.25/PRNewswire/-SentinelleMedic...ncedvisualizationsoftwarelaunchesasuiteofnewleadin...ingsoftwareplatformatthisyear,sRadiologicalSociety...Dec.5,2009(Booth5800,HallA).Theapplicationsleverag...specializedMRIimagingcoilsandsupportmultipleimagin...
(Date:11/25/2009)...,, LOSANGELES,Nov.25/PRNewswire-USNewswire/--...ectionstodetermineexecutiveleadershipfor2010. ,...swithspecialtiesinpublicpolicy,law,finance,governm...rship.TheBoardalsocomesfromawiderangeofpersonalbac...women,somelivingwithHIVthemselves,andrepresentingm...
(Date:11/25/2009)... Long-term survivors of testicular cancer who wer...re severe side effects, including neurological sid... were not treated with chemotherapy, according to ...ournal of the National Cancer Institute . , Mari...aukeland University Hospital, in Bergen, Norway, a...
(Date:11/25/2009)... Does stress increase blood pressure? This simpl...for many years. New Stress-related gene Modulates...ncrease blood pressure? This simple question has ... Now new research has for the first time establis...e blood pressure response to stress in mice as wel...
Breaking Medicine News(10 mins):Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:New stress-related gene modulates high blood pressure in mice and men 2
...J Officials, Legal Experts to Discuss Latest Crimi...and Dietary Supplement,Industries, WASHINGTON, De... companies have agreed to pay more than $1.9,billi...or know about the crimes., With the Federal Gover...
...ugh the new Agri-Opportunities program of Agricult...) -, BELLEVILLE, ON, Dec. 20 /PRNewswire-FirstCal...earch-based, technology-driven Canadian,biopharmac...p in Belleville, Ontario. The $5 million repayable...
...a, PA, December 20, 2007 For U.S. veterans with d...unctioning are associated with an increased risk o...er/December issue of the journal General Hospital ...appropriate interventions to counteract this highe...
.... and CHARLESTON, S.C., Dec. 20 LTC,Financial Par...e insurance,brokerage, has more than quadrupled in...ers and support staff. That just one sign of what,...pg), *(Photo Caption: LTC Financial CEO Cameron T...
...lapharma.com Toronto Stock Exchange Symbol: AKL, ...Pharma Inc. (TSX:,"AKL"), a drug development compa...ion and pain markets, today announced that due to ...y is currently,contemplating other financing optio...
...team led by Dr. Paul Wiseman of the Departments of...veloped a radically new technique that uses lasers...infection in human blood, according to a study pub...of the malaria parasite in blood samples. , Malar...
Other Medicine News:Health News:Food and Drug Law Institute Sponsors Major Enforcement Conference 2Health News:Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario 2Health News:Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario 3Health News:Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario 4Health News:Bioniche Receives $5 Million of Federal Government Support to Scale-up Vaccine Production in Ontario 5Health News:Mental health linked to amputation risk in diabetic veterans 2Health News:The Long Term Care Insurance Explosion; January Conference to Celebrate Rapid Growth of LTC Protection and Light Fuse of Further Expansion 2Health News:Akela Pharma provides corporate update 2Health News:McGill researchers report breakthrough in rapid malaria detection 2
ExcaliburPlus PC, 100V, 50Hz/60Hz
ExcaliburPlus PC, 220V, 50Hz
Bipolar Coagulator
Elmed BC 50 M/M
Medicine Products: